Lumos Pharma
is a clinical-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read moreLumos Pharma
is a clinical-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
News
Dec 18, 2024
Global Legal Chronicle
Lumos Pharma: Lumos Pharma's Tender Offer and Merger with Double Point Ventures
Nov 21, 2024
GlobalNewswire
Press Release: Lumos Pharma : Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201's Unique Pulsatile Mechanism of Action
Nov 07, 2024
Owler
Lumos Pharma, Inc.: Lumos Pharma's revenue changed from $1.49M in Jun 2024 to $2.21M in Sep 2024
Nov 06, 2024
Benzinga
Lumos Pharma: SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Lumos Pharma Inc. - LUMO
Oct 24, 2024
Pharamceutical Technology
Lumos Pharma: DPV set to acquire Lumos Pharma for $38m
Sep 25, 2024
Benzinga
Lumos Pharma: Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
Aug 15, 2024
GlobeNewswire
Press Release: Lumos Pharma : Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Jun 04, 2024
GlobalNewswire
Press Release: Lumos Pharma : Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
May 20, 2024
GlobeNewswire
Press Release: Lumos Pharma : Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
May 20, 2024
MarketScreener
Lumos Pharma: Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
Lumos Pharma Competitors
1
2
3
4
5
6
7
8
9
10